Zobrazeno 1 - 10
of 478
pro vyhledávání: '"Legos Jj"'
Autor:
Daly B; Department of Medicine, Memorial Sloan Kettering Cancer Center and Weill Cornell Medicine, New York, New York., Brawley OW; School of Medicine, Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland., Gospodarowicz MK; Princess Margaret Cancer Center, University of Toronto, Toronto, Ontario, Canada., Olopade OI; Medicine and Human Genetics, Center for Clinical Cancer Genetics and Global Health, University of Chicago Medical Center, Chicago, Illinois., Fashoyin-Aje L; Oncology Center of Excellence, US Food and Drug Administration, Silver Spring, Maryland., Smart VW; Susan G. Komen Foundation, Dallas, Texas., Chang IF; Amgen Inc, Thousand Oaks, California., Tendler CL; Janssen, Johnson & Johnson, New Brunswick, New Jersey., Kim G; BeiGene, Cambridge, Massachusetts., Fuchs CS; Genentech, South San Francisco, California.; Yale Cancer Center, Yale School of Medicine, New Haven, Connecticut., Beg MS; Science 37, Durham, North Carolina.; Internal Medicine, Gastrointestinal Oncology, Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, Texas., Zhang L; Jiangsu Hengrui Pharmaceuticals, Shanghai, China., Legos JJ; Novartis, Basel, Switzerland., Duran CO; AstraZeneca, Cambridge, United Kingdom., Kalidas C; Bayer, Leverkusen, Germany., Qian J; Asia Society, New York, New York., Finnegan J; Bloomberg New Economy, Bloomberg LP, New York, New York., Pilarski P; McKinsey Cancer Center, McKinsey & Company, New York, New York., Keane H; McKinsey Cancer Center, McKinsey & Company, New York, New York., Shen J; McKinsey Cancer Center, McKinsey & Company, New York, New York., Silverstein A; McKinsey Cancer Center, McKinsey & Company, New York, New York., Wu YL; Guangdong Lung Cancer Institute, Chinese Thoracic Oncology Group, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China., Pazdur R; Oncology Center of Excellence, US Food and Drug Administration, Silver Spring, Maryland., Li BT; Department of Medicine, Memorial Sloan Kettering Cancer Center and Weill Cornell Medicine, New York, New York.
Publikováno v:
JAMA network open [JAMA Netw Open] 2024 Apr 01; Vol. 7 (4), pp. e246228. Date of Electronic Publication: 2024 Apr 01.
Autor:
Long GV, Flaherty KT, Stroyakovskiy D, Gogas H, Levchenko E, de Braud F, Larkin J, Garbe C, Jouary T, Hauschild A, Chiarion-Sileni V, Lebbe C, Mandalá M, Millward M, Arance A, Bondarenko I, Haanen JBAG, Hansson J, Utikal J, Ferraresi V, Mohr P, Probachai V, Schadendorf D, Nathan P, Robert C, Ribas A, Davies MA, Lane SR, Legos JJ, Mookerjee B, Grob JJ
Publikováno v:
Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2019 Nov 01; Vol. 30 (11), pp. 1848.
Publikováno v:
Neuroreport. 11(17)
PEP-19 is a calmodulin-regulatory protein found specifically within neurons, though cellular functions of this protein have not been determined. In an effort to define potential effects of PEP-19, PC12 cell lines expressing this protein were generate
Autor:
McQuade JL; University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address: jmcquade@mdanderson.org., Daniel CR; University of Texas MD Anderson Cancer Center, Houston, TX, USA., Hess KR; University of Texas MD Anderson Cancer Center, Houston, TX, USA., Mak C; Novartis Pharmaceuticals, East Hanover, NJ, USA., Wang DY; Vanderbilt University Medical Center, Nashville, TN, USA., Rai RR; Melanoma Institute Australia and University of Sydney, North Sydney, NSW, Australia., Park JJ; Crown Princess Mary Cancer Centre, Westmead Hospital, Westmead NSW, Australia., Haydu LE; University of Texas MD Anderson Cancer Center, Houston, TX, USA., Spencer C; University of Texas MD Anderson Cancer Center, Houston, TX, USA., Wongchenko M; Genentech, San Francisco, CA, USA., Lane S; Novartis Pharmaceuticals, East Hanover, NJ, USA., Lee DY; Novartis Pharmaceuticals, East Hanover, NJ, USA., Kaper M; Novartis Pharmaceuticals, East Hanover, NJ, USA., McKean M; University of Texas MD Anderson Cancer Center, Houston, TX, USA., Beckermann KE; Vanderbilt University Medical Center, Nashville, TN, USA., Rubinstein SM; Vanderbilt University Medical Center, Nashville, TN, USA., Rooney I; Genentech, San Francisco, CA, USA., Musib L; Genentech, San Francisco, CA, USA., Budha N; Genentech, San Francisco, CA, USA., Hsu J; Genentech, San Francisco, CA, USA., Nowicki TS; University of California Los Angeles Medical Center, Los Angeles, CA, USA., Avila A; Bristol-Myers Squibb, New York, NY, USA., Haas T; Novartis Pharmaceuticals, East Hanover, NJ, USA., Puligandla M; Dana-Farber Cancer Institute, Boston, MA, USA., Lee S; Dana-Farber Cancer Institute, Boston, MA, USA., Fang S; University of Texas MD Anderson Cancer Center, Houston, TX, USA., Wargo JA; University of Texas MD Anderson Cancer Center, Houston, TX, USA., Gershenwald JE; University of Texas MD Anderson Cancer Center, Houston, TX, USA., Lee JE; University of Texas MD Anderson Cancer Center, Houston, TX, USA., Hwu P; University of Texas MD Anderson Cancer Center, Houston, TX, USA., Chapman PB; Memorial Sloan Kettering Cancer Center, New York, NY, USA., Sosman JA; Northwestern University, Chicago, IL, USA., Schadendorf D; University Hospital Essen and German Cancer Consortium, Essen, Germany., Grob JJ; Centre Hospitalo-Universitaire Timone, Aix Marseille University, Marseille, France., Flaherty KT; Massachusetts General Hospital Cancer Center, Boston, MA, USA., Walker D; Bristol-Myers Squibb, New York, NY, USA., Yan Y; Genentech, San Francisco, CA, USA., McKenna E; Genentech, San Francisco, CA, USA., Legos JJ; Novartis Pharmaceuticals, East Hanover, NJ, USA., Carlino MS; Melanoma Institute Australia and University of Sydney, North Sydney, NSW, Australia; Crown Princess Mary Cancer Centre, Westmead Hospital, Westmead NSW, Australia., Ribas A; University of California Los Angeles Medical Center, Los Angeles, CA, USA., Kirkwood JM; Hillman University of Pittsburgh Medical Center Cancer Center, Pittsburgh, PA, USA., Long GV; Melanoma Institute Australia and University of Sydney, North Sydney, NSW, Australia; Royal North Shore and Mater Hospitals, St Leonards, NSW, Australia., Johnson DB; Vanderbilt University Medical Center, Nashville, TN, USA., Menzies AM; Melanoma Institute Australia and University of Sydney, North Sydney, NSW, Australia; Royal North Shore and Mater Hospitals, St Leonards, NSW, Australia., Davies MA; University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Publikováno v:
The Lancet. Oncology [Lancet Oncol] 2018 Mar; Vol. 19 (3), pp. 310-322. Date of Electronic Publication: 2018 Feb 12.
Autor:
Schadendorf D; Department of Dermatology, University Hospital Essen, Hufelandstrasse 55, 45122 Essen, Germany; German Cancer Consortium, 69117 Heidelberg, Germany. Electronic address: Dirk.Schadendorf@uk-essen.de., Long GV; Melanoma Institute Australia, The University of Sydney, NSW, Australia; Mater Hospital, North Sydney, NSW, Australia; Royal North Shore Hospital, St Leonards, NSW, Australia., Stroiakovski D; Moscow City Oncology Hospital No 62, Moscow 143423, Russia., Karaszewska B; Przychodnia Lekarska KOMED, Wojska Polskiego 6, 62-500 Konin, Poland., Hauschild A; Department of Dermatology, University Medical Center Schleswig-Holstein, Arnold-Heller-Straße 3, 24105 Kiel, Germany., Levchenko E; Petrov Research Institute of Oncology, 68 Leningradskaya Street, Saint Petersburg 197758, Russia., Chiarion-Sileni V; Melanoma and Esophageal Oncology Unit, Veneto Oncology Institute-IRCCS, Via Gattamelata 64, 35128 Padova, Italy., Schachter J; Oncology Division, Sheba Medical Center, Tel HaShomer, Emek HaEla St 1, Ramat Gan, Israel., Garbe C; Department of Dermatology, University of Tübingen, Geschwister-Scholl-Platz, 72074 Tübingen, Germany., Dutriaux C; Service de Dermatologie et Dermatologie Pédiatrique, Hôpital Saint-André, 1 Rue Jean Burguet, 33000 Bordeaux, France., Gogas H; First Department of Medicine, 'Laiko' General Hospital, National and Kapodistrian University of Athens, Athens 157 72, Greece., Mandalà M; Department of Oncology and Hematology, Papa Giovanni XXIII Hospital, Bergamo, Italy., Haanen JBAG; Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands., Lebbé C; APHP Dermatology and CIC Departments, INSERM U976, University Paris Diderot, Paris, France., Mackiewicz A; Department of Cancer Immunology, Poznan University of Medical Sciences, 15 Garbary Street, 61-866 Poznań, Poland., Rutkowski P; Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Wawelska 15B, 02-034 Warsaw, Poland., Grob JJ; Department of Dermatology, University Hospital Center, Timone Hospital, Aix Marseille University, 264 Rue St Pierre, 13885 Marseille Cedex 05, France., Nathan P; Mount Vernon Cancer Centre, Rickmansworth Road, HA6 2RN Northwood, UK., Ribas A; Department of Medicine, Hematology/Oncology, UCLA Medical Center, 100 UCLA Medical Plaza, Suite 550, Los Angeles, CA, USA., Davies MA; Melanoma Medical Oncology and Systems Biology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston 77030, TX, USA., Zhang Y; Novartis Pharmaceuticals Corporation, 1 Health Plaza, East Hanover 07936, NJ, USA., Kaper M; Novartis Pharmaceuticals Corporation, 1 Health Plaza, East Hanover 07936, NJ, USA., Mookerjee B; Novartis Pharmaceuticals Corporation, 1 Health Plaza, East Hanover 07936, NJ, USA., Legos JJ; Novartis Pharmaceuticals Corporation, 1 Health Plaza, East Hanover 07936, NJ, USA., Flaherty KT; Developmental Therapeutics and Melanoma Programs, Massachusetts General Hospital Cancer Center, 55 Fruit Street, Boston 02114, MA, USA., Robert C; Department of Medical Oncology, Dermatology Service, Gustave Roussy Comprehensive Cancer Center and Faculty of Medicine, University Paris-South, F-94805, Villejuif, France.
Publikováno v:
European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2017 Sep; Vol. 82, pp. 45-55. Date of Electronic Publication: 2017 Jun 22.
Autor:
Long GV; Melanoma Institute Australia, The University of Sydney, and Royal North Shore and Mater Hospitals, North Sydney, Australia., Flaherty KT; Developmental Therapeutics and Melanoma Programs, Massachusetts General Hospital Cancer Center, Boston, USA., Stroyakovskiy D; Moscow City Oncology Hospital #62, Moscow, Russia., Gogas H; First Department of Medicine, 'Laiko' General Hospital, National and Kapodistrian University of Athens, Athens, Greece., Levchenko E; Petrov Research Institute of Oncology, Saint Petersburg, Russia., de Braud F; Dipartimento di Medicina Oncologica, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Larkin J; Royal Marsden NHS Foundation Trust, London, UK., Garbe C; Department of Dermatology, University of Tübingen, Tübingen, Germany., Jouary T; Service D'oncologie Médicale, Hopital Francois Mitterrand, Pau, France., Hauschild A; Department of Dermatology, University Hospital Schleswig-Holstein, Kiel, Germany., Chiarion-Sileni V; Melanoma and Oesophageal Oncology Unit, Veneto Oncology Institute-IRCCS, Padova, Italy., Lebbe C; APHP Dermatology and CIC Departments, INSERM U976, University Paris Diderot, Paris, France., Mandalà M; Department of Oncology and Hematology, Papa Giovanni XXIII Hospital, Bergamo, Italy., Millward M; Medical Oncology Department, Sir Charles Gairdner Hospital, Perth, Australia., Arance A; Department of Medical Oncology, Hospital Clinic of Barcelona, Barcelona, Spain., Bondarenko I; Dnipropetrovsk State Medical Academy, Clinical Hospital #4, Dnipropetrovsk, Ukraine., Haanen JBAG; Netherlands Cancer Institute, Amsterdam, The Netherlands., Hansson J; Department of Oncology-Pathology, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden., Utikal J; Skin Cancer Unit, German Cancer Research Center (DKFZ) and Department of Dermatology, Venereology and Allergology, University Medical Center Mannheim, Ruprecht-Karls University of Heidelberg, Mannheim and Heidelberg, Germany., Ferraresi V; Department of Medical Oncology A, Regina Elena National Cancer Institute, Rome, Italy., Mohr P; Dermatologisches Zentrum Buxtehude, Elbe Kliniken Buxtehude, Buxtehude, Germany., Probachai V; Dnipropetrovsk Clinical Oncology Center of Dnipropetrovsk State Council, Dnipropetrovsk, Ukraine., Schadendorf D; Department of Dermatology, University Hospital Essen, Essen, Germany.; German Cancer Consortium, Heidelberg, Germany., Nathan P; Mount Vernon Cancer Centre, Northwood, UK., Robert C; Gustave Roussy, Département de Médecine Oncologique, Service de Dermatologie et Université Paris-Sud, Faculté de Médecine, Villejuif, France., Ribas A; Department of Medicine, Hematology/Oncology, UCLA Jonsson Comprehensive Cancer Center, Los Angeles, USA., Davies MA; Melanoma Medical Oncology and Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, USA., Lane SR; Novartis Pharmaceuticals Corporation, East Hanover, USA., Legos JJ; Novartis Pharmaceuticals Corporation, East Hanover, USA., Mookerjee B; Novartis Pharmaceuticals Corporation, East Hanover, USA., Grob JJ; Service de Dermatologie, Centre Hospitalo-Universitaire Timone, Aix-Marseille Université, Marseille, France.
Publikováno v:
Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2017 Jul 01; Vol. 28 (7), pp. 1631-1639.
Autor:
Iacono, Diego1,2,3,4,5,6 (AUTHOR) diego.iacono.ctr@usuhs.edu, Hatch, Kathleen1,3,5 (AUTHOR), Murphy, Erin K.1,3,5 (AUTHOR), Post, Jeremy7 (AUTHOR), Cole, Robert N.7 (AUTHOR), Perl, Daniel P.1,3 (AUTHOR), Day, Regina M.8 (AUTHOR)
Publikováno v:
PLoS ONE. 3/1/2024, Vol. 19 Issue 2, p1-18. 18p.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.